225 related articles for article (PubMed ID: 27325649)
1. Therapeutic Efficacy of Cancer Stem Cell Vaccines in the Adjuvant Setting.
Hu Y; Lu L; Xia Y; Chen X; Chang AE; Hollingsworth RE; Hurt E; Owen J; Moyer JS; Prince ME; Dai F; Bao Y; Wang Y; Whitfield J; Xia JC; Huang S; Wicha MS; Li Q
Cancer Res; 2016 Aug; 76(16):4661-72. PubMed ID: 27325649
[TBL] [Abstract][Full Text] [Related]
2. Generation of a novel dendritic-cell vaccine using melanoma and squamous cancer stem cells.
Li Q; Lu L; Tao H; Xue C; Teitz-Tennenbaum S; Owen JH; Moyer JS; Prince ME; Chang AE; Wicha MS
J Vis Exp; 2014 Jan; (83):e50561. PubMed ID: 24430104
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of an ALDH peptide-based dendritic cell vaccine targeting cancer stem cells.
Liao F; Zhang J; Hu Y; Najafabadi AH; Moon JJ; Wicha MS; Kaspo B; Whitfield J; Chang AE; Li Q
Cancer Immunol Immunother; 2022 Aug; 71(8):1959-1973. PubMed ID: 35098344
[TBL] [Abstract][Full Text] [Related]
4. Cancer Stem Cell Vaccination With PD-L1 and CTLA-4 Blockades Enhances the Eradication of Melanoma Stem Cells in a Mouse Tumor Model.
Zheng F; Dang J; Zhang H; Xu F; Ba D; Zhang B; Cheng F; Chang AE; Wicha MS; Li Q
J Immunother; 2018 Oct; 41(8):361-368. PubMed ID: 30063587
[TBL] [Abstract][Full Text] [Related]
5. Cancer stem cell vaccine inhibits metastases of primary tumors and induces humoral immune responses against cancer stem cells.
Lu L; Tao H; Chang AE; Hu Y; Shu G; Chen Q; Egenti M; Owen J; Moyer JS; Prince ME; Huang S; Wicha MS; Xia JC; Li Q
Oncoimmunology; 2015 Mar; 4(3):e990767. PubMed ID: 25949905
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the immunogenicity of ALDH(high) human head and neck squamous cell carcinoma cancer stem cells in vitro.
Prince MEP; Zhou L; Moyer JS; Tao H; Lu L; Owen J; Etigen M; Zheng F; Chang AE; Xia J; Wolf G; Wicha MS; Huang S; Ren X; Li Q
Oral Oncol; 2016 Aug; 59():30-42. PubMed ID: 27424180
[TBL] [Abstract][Full Text] [Related]
7. Integrin β4-Targeted Cancer Immunotherapies Inhibit Tumor Growth and Decrease Metastasis.
Ruan S; Lin M; Zhu Y; Lum L; Thakur A; Jin R; Shao W; Zhang Y; Hu Y; Huang S; Hurt EM; Chang AE; Wicha MS; Li Q
Cancer Res; 2020 Feb; 80(4):771-783. PubMed ID: 31843981
[TBL] [Abstract][Full Text] [Related]
8. Effective tumor immunity to melanoma mediated by B16F10 cancer stem cell vaccine.
Zhao F; Zhang R; Wang J; Wu D; Pan M; Li M; Guo M; Dou J
Int Immunopharmacol; 2017 Nov; 52():238-244. PubMed ID: 28950176
[TBL] [Abstract][Full Text] [Related]
9. Synergy of Dendritic Cell Vaccines and Avasimibe in Treatment of Head and Neck Cancer in Mice.
Chen X; Song Q; Xia L; Xu X
Med Sci Monit; 2017 Sep; 23():4471-4476. PubMed ID: 28918429
[TBL] [Abstract][Full Text] [Related]
10. Dendritic cell based immunotherapy using tumor stem cells mediates potent antitumor immune responses.
Dashti A; Ebrahimi M; Hadjati J; Memarnejadian A; Moazzeni SM
Cancer Lett; 2016 Apr; 374(1):175-185. PubMed ID: 26803056
[TBL] [Abstract][Full Text] [Related]
11. Potentiation of immunologic responsiveness to dendritic cell-based tumor vaccines by recombinant interleukin-2.
Shimizu K; Fields RC; Redman BG; Giedlin M; Mulé JJ
Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S67-75. PubMed ID: 10685663
[TBL] [Abstract][Full Text] [Related]
12. Dual-targeted therapeutic strategy combining CSC-DC-based vaccine and cisplatin overcomes chemo-resistance in experimental mice model.
El-Ashmawy NE; Salem ML; Khedr EG; El-Zamarany EA; Ibrahim AO
Clin Transl Oncol; 2020 Jul; 22(7):1155-1165. PubMed ID: 31748959
[TBL] [Abstract][Full Text] [Related]
13. Ovarian Cancer Stem Cells with High ROR1 Expression Serve as a New Prophylactic Vaccine for Ovarian Cancer.
Wu D; Yu X; Wang J; Hui X; Zhang Y; Cai Y; Ren M; Guo M; Zhao F; Dou J
J Immunol Res; 2019; 2019():9394615. PubMed ID: 31008116
[TBL] [Abstract][Full Text] [Related]
14. Preventive cancer stem cell-based vaccination reduces liver metastasis development in a rat colon carcinoma syngeneic model.
Duarte S; Momier D; Baqué P; Casanova V; Loubat A; Samson M; Guigonis JM; Staccini P; Saint-Paul MC; De Lima MP; Carle GF; Pierrefite-Carle V
Stem Cells; 2013 Mar; 31(3):423-32. PubMed ID: 23193035
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic properties of DNA-based fibroblast and dendritic cell vaccines in mice with squamous carcinoma.
O-Sullivan I; Kim TS; Chopra A; Cohen EP
Anticancer Res; 2006; 26(2A):873-84. PubMed ID: 16619482
[TBL] [Abstract][Full Text] [Related]
16. Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis.
Marcato P; Dean CA; Pan D; Araslanova R; Gillis M; Joshi M; Helyer L; Pan L; Leidal A; Gujar S; Giacomantonio CA; Lee PW
Stem Cells; 2011 Jan; 29(1):32-45. PubMed ID: 21280157
[TBL] [Abstract][Full Text] [Related]
17. Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines.
Wang J; Saffold S; Cao X; Krauss J; Chen W
J Immunol; 1998 Nov; 161(10):5516-24. PubMed ID: 9820528
[TBL] [Abstract][Full Text] [Related]
18. Effect of targeted ovarian cancer immunotherapy using ovarian cancer stem cell vaccine.
Wu D; Wang J; Cai Y; Ren M; Zhang Y; Shi F; Zhao F; He X; Pan M; Yan C; Dou J
J Ovarian Res; 2015 Oct; 8():68. PubMed ID: 26497895
[TBL] [Abstract][Full Text] [Related]
19. An effective dendritic cell-based vaccine containing glioma stem-like cell lysate and CpG adjuvant for an orthotopic mouse model of glioma.
Zhu S; Lv X; Zhang X; Li T; Zang G; Yang N; Wang X; Wu J; Chen W; Liu YJ; Chen J
Int J Cancer; 2019 Jun; 144(11):2867-2879. PubMed ID: 30565657
[TBL] [Abstract][Full Text] [Related]
20. A new strategy for enhancing antitumor immune response using dendritic cells loaded with chemo-resistant cancer stem-like cells in experimental mice model.
El-Ashmawy NE; El-Zamarany EA; Salem ML; Khedr EG; Ibrahim AO
Mol Immunol; 2019 Jul; 111():106-117. PubMed ID: 31051312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
